David Lebwohl - EVP, Chief Medical Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Medical Officer
Stock Symbol
NTLA on Nasdaq
All Insider Reports
All Insider Reports

David Lebwohl - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by David Lebwohl for Intellia Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 93.1K $2.73M $29.38 Mar 1, 2024 Direct
Restricted Stock Unit 3.19K $76.2K $23.90 Jan 1, 2024 Direct Common Stock
Stock Option (right to buy) 55.9K Mar 1, 2024 Direct Common Stock

Transactions reported by David Lebwohl for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.